The combination of oral and small intestinal mucositis, pediatrics and biomarkers: A particularly tricky problem!

Cancer Biology and Therapy

Volumn 5, Issue 10, 2006, Pages 1282-1284

  Keefe, Dorothy M ^a,b   Gibson, Rachel J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cancer; Chemotherapy; Mucositis; Non invasive; Pediatrics; Small intestine; Sucrose breath test

Indexed keywords

BIOLOGICAL MARKER; SUCROSE;

BREATH ANALYSIS; CANCER CHEMOTHERAPY; CELL HETEROGENEITY; CELL MEMBRANE PERMEABILITY; CLINICAL STUDY; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTESTINE BIOPSY; MUCOSA INFLAMMATION; NONHUMAN; NOTE; RISK FACTOR; SMALL INTESTINE MUCOSA; WORLD HEALTH ORGANIZATION;

EID: 33751120388     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.10.3508     Document Type: Note

References (30)

1. Gibson RJ, Cummins AG, Bowen JM, Logan RM, Healey T, Keefe DMK. Apoptosis occurs early in the basal layer of the oral mucosa following cancer chemotherapy. Asia Pacific Journal of Clinical Oncology 2006; 2:39-49.
2. Sonis ST. The pathobiology of mucositis. Nature Reviews: Cancer 2004; 4:277-84.
3. Sonis ST, Fey EG. Oral complications of cancer therapy. Oncology 2002; 16:680-95.
4. Sonis ST, Tracey C, Shklar G, Jenson J, Florine D. An animal model for mucositis induced by cancer chemotherapy. Oral Surgery, Oral Medicine, Oral Pathology 1990; 69:437-43.
5. Gibson RJ, Bowen JM, Cummins AG, Keefe DMK. Relationship between chemotherapy and subsequent apoptosis and damage in the gastrointestinal tract of the rat with breast cancer. Clinical and Experimental Medicine 2005; 4:188-95.
6. Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DMK. Irinotecan causes severe small intestinal damage as well as colonic damage in the rat with implanted breast cancer. Journal of Gastroenterology and Hepatology 2003; 18:1095-100.
7. Gibson RJ, Keefe DMK, Clarke JM, Regester GO, Thompson FM, Goland GJ, Edwards BE, Cummins AG. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemotherapy & Pharmacology 2002; 50:53-8.
8. Gibson RJ, Keefe DMK, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Digestive Diseases & Sciences 2002; 47:2751-7.
9. Keefe DMK. The effect of cytotoxic chemotherapy on the mucosa of the small intestine. MD Thesis, University of Adelaide, Department of Medicine 1998.
10. Childers NK, Stinnett EA, Wheeler P, Wright JT, Castleberry RP, Dasanayake AP. Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol 1993; 75:41-7.
11. Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, Guerin J, Bergeron C, LeGall E. Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. Eur J Cancer 1998; 34:1588-91.
12. Cummins AG, Thompson FM. Effect of breast milk and weaning on epithelial growth of the small intestine in humans. Gut 2002; 51:748-54.
13. Cummins AG, Jones BJ, Thompson FM. Postnatal epithelial growth of the small intestine in the rat occurs by both crypt fission and crypt hyperplasia. Dig Dis Sci 2006; 51:718-23.
14. Camac KS, Thompson FM, Cummins AG. Activation of b-catenin in the stem cell region of crypts during growth of the small intestine in infant rats. Dig Dis Sci 2006; In press.
15. Thompson FM, Mayrhofer G, Cummins AG. Dependence of epithelial growth of the small intestine on T-cell activation during weaning in the rat. Gastroenterology 1996; 111:37-44.
16. Thompson FM, Catto-Smith AG, Moore D, Davidson G, Cummins AG. Epithelial growth of the small intestine in human infants. J Pediatr Gastroenterol Nutr 1998; 26:506-12.
17. Sonis ST. A biological approach to mucositis. J Support Oncol 2004; 2:21-32; discussion 5-6.
18. Sonis ST, Elting LS, Keefe DM, Peterson DE, Schubert MM, Hauer-Jenson M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein E. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004; 100:1995-2025.
19. Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of high-dose chemotherapy on intestinal permeability in humans. Clinical Science 1997; 92:385-9.
20. Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47:632-7.
21. Keefe DM, Gibson RJ, Hauer-Jenson M. Gastrointestinal Mucositis. Seminars in Oncology Nursing 2004; 20:38-47.
22. Keefe DM. Gastrointestinal mucositis: a new biological model. Support Care Cancer 2004; 12:6-9.
23. Keefe DM, Peterson DE, Schubert MM. Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls. Support Care Cancer 2006; 14:492-8.
24. Keefe DMK. Mucositis management in patients with cancer. Supportive Cancer Therapy 2006; 3:154-7.
25. Keefe DM. Mucositis guidelines: what have they achieved, and where to from here? Support Care Cancer 2006; 14:489-91.
26. Keefe DM, Gibson RJ. Sucrose Breath Testing and Intestinal Mucositis. Cancer Biol Ther 2006; 5:1196-8.
27. Howarth GS, Tooley KL, Davidson GP, Butler RN. A Non-Invasive Method for Detection of Intestinal Mucositis Induced by Different Classes of Chemotherapy Drugs in the Rat. Cancer Biol Ther 2006; 5:In press.
28. Miki K, Butler R, Moore D, Davidson G. Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice. Clin Chem 1996; 42:71-5.
29. Pelton NS, Tivey DR, Howarth GS, Davidson GP, Butler RN. A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scand J Gastroenterol 2004; 39:1015-6.
30. Clarke JM, Pelton NC, Bajka BH, Howarth GS, Read LC, Butler RN. Use of the 13Csucrose breath test to assess chemotherapy-induced small intestinal mucositis in the rat. Cancer Biol Ther 2006; 5:34-8.